
Conference Research
We invite you to explore accepted abstracts in biomedical science, clinical research, public health, and epidemiology.

The Research Review Process
Abstracts were evaluated by judges in their respective fields of expertise.
Judges independently assigned scores on a 1 to 10 scale, which were then averaged.
The resulting average scores were used in determining the abstract ranking.
Oral presenters were chosen based on presentation preference and overall score ranking.
—
Thank you to our expert panel of Filipinx researchers who helped judge our symposium entries this year!
Oral & Poster Presentations
-
Shiyun Cao (1,2,#), Sheena Faye Garcia (3,4,#) , Huigang Shi (1,2,#), Ellie I. James (5,6), Yuki Kito (3,4), Hui Shi (1,2,†), Haibin Mao (1,2), Sharon Kaisari (3,4), Gergely Rona (3,4,7,8), Sophia Deng (3,4), Hailey V. Goldberg (3,4), Jackeline Ponce (3,4,9), Beatrix Ueberheide (3,4,9), Luca Lignitto (3,4,10), Miklos Guttman (5,6), Michele Pagano (3,4,7,*), & Ning Zheng (1,2,11,*)
(1)Department of Pharmacology, Box 357280, University of Washington, Seattle, WA, USA 2Howard Hughes Medical Institute, University of Washington, Seattle, WA, 98195, USA
(3)Department of Biochemistry and Molecular Pharmacology, 4Laura and Isaac Perlmutter Cancer Center, New York University Grossman School of Medicine, New York, NY 10016, USA
(5)Department of Medicinal Chemistry, 6Molecular Engineering & Science Institute, University of Washington, Seattle, WA,98195, USA
(7)Howard Hughes Medical Institute, New York University Grossman School of Medicine, New York, NY 10016, USA (8)Institute of Molecular Life Sciences, HUN-REN Research Centre of Natural Sciences, Budapest, Hungary. (9)Proteomics Laboratory, Division of Advanced Research Technologies, New York University Grossman School of Medicine, New York, NY 10016, USA
(10)Cancer Research Center of Marseille (CRCM), CNRS, Aix Marseille Univ, INSERM, Institut Paoli-Calmettes, Marseille, France
(11)Lead contact
Present Address: (†)Biortus Discovery Co., Ltd. 101 South Building, 99-3 Linhu Avenue, Xinwu
District, Wuxi, Jiangsu, P.R. China
#These authors contributed equally to this work.
*Correspondence: michele.pagano@nyumc.org, nzheng@uw.edu
Ubiquitin-dependent proteolysis regulates diverse cellular functions with high substrate specificity. The precision of this regulatory mechanism hinges on the ability of E3 ubiquitin ligases to decode target degradation signals i.e. degrons, which canonically present as short linear motifs. We show that BACH1, a transcriptional repressor of antioxidant response genes, features two distinct unconventional degrons encrypted in the quaternary structure of its homodimeric BTB domain. These two degrons are both functionalized by oxidative stress and are deciphered by two complementary E3 ligases from the CRL1 family: FBXO22 and FBXL17. FBXO22 recognizes a degron constructed by the BACH1 BTB domain dimer interface, which is unmasked from transcriptional co-repressors after BACH1 is released from chromatin upon oxidative stress. When this degron is impaired by oxidation, a second BACH1 degron, manifested by the resulting BTB dimer with compromised integrity, is probed by a pair of FBXL17 that remodels the two BTB protomers into E3-bound monomers for ubiquitination. Our findings reveal the remarkable multidimensionality of protein degradation signals underpinning substrate selectivity and functional versatility of ubiquitin-dependent proteolysis.
KEYWORDS: Ubiquitin-proteasome system, oxidative stress, protein degradation, cryo-EM -
Gabriel P. Ordonez (1), Lauren F. Uchiyama, PhD (2), Khoi Pham (1), John P. Kennelly (2), Lany D. Tran (1), Peter Tontonoz, MD, PhD (2,3), Alexander H. Nguyen, MD, PhD (1)
(1)Vatche and Tamar Manoukian Division of Digestive Diseases, Department of Medicine, David Geffen School
Medicine, University of California, Los Angeles (UCLA) & UCLA Health;
(2)Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCL
(3)Department of Biological Chemistry, David Geffen School of Medicine at UC
Abstract: Peroxisome proliferator-activated receptor alpha (PPARa) is a nuclear hormone receptor that transcriptionally regulates lipid homeostasis and the liver fasting response through lipid uptake and catabolism. In humans, PPARa non-synonymous single nucleotide polymorphism (nsSNP) Val227Ala (V227A) occurs in East Asians with up to a 4% allele frequency. Clinical studies associate this variant with beneficial metabolic paramete including reduced plasma triacylglycerols (TG) and cholesterol, decreased metabolic dysfunction-associated steatotic liver disease (MASLD) incidence, and lowered body-mass index. Whether these correlations reflect causal relationship has not been physiologically modeled. To address this, we generated a V227A mouse model via CRISPR/Cas-mediated base editing of the endogenous Ppara gene locus. Base editing in mouse cell lines and pronuclei exhibits high editing efficiency. V227A mice display no difference in body or liver mass or hepatic accumulation. However, they exhibited decreased plasma TG, prominently under lipid-rich Western diet, aligning with clinical findings. Liver RNA sequencing confirmed upregulation of Ppara targets, including lipoprotein li (Lpl), the key enzyme in plasma TG hydrolysis. Gene expression analyses revealed increased liver and heart Lpl mRNA in fasted V227A mice. Notably, fasting and pharmacologic Ppara agonists induce Lpl mRNA, consistent with Lpl being a direct target. Functional TG assays showed increased TG uptake in the heart, and fluorometr assays confirmed elevated cardiac LPL activity. These findings suggest enhanced peripheral TG hydrolysis dr reduced plasma TG levels. Our study reveals a mechanistic link between PPARa-V227A and metabolic health, offering insights into human genetic variation and potential therapeutic targets in metabolic disease
Keywords: lipid metabolism, physiology, human genetic variation
-
David V.Pack (*1), Madelyn O. Sijangga (*1), Nicole O. Yokota (1), Morgan H. Vien (1), Alexander D. G. Dryland (1), and Susan L. Ivey (1)
(1) Health Research for Action, School of Public Health, University of California, Berkeley, Berkeley, CA
*These authors have contributed equally to this work and share first authorship
Abstract: Among Asian American subgroups, Filipino-Americans have consistently been shown to have the highest rates of hypertension, raising risks of heart attack and stroke. Despite this fact, little has been done to investigate culturally-sensitive interventions to control hypertension rates in this population. To address the lack of culturally-relevant lifestyle options for blood pressure management currently available to the Filipino community, this pilot study used a design thinking approach informed by culinary medicine to develop a culturally-tailored, heart-healthy, and low sodium recipe cookbook for Filipino Americans with hypertension and evaluate its feasibility as a hypertension intervention. Our team developed a cookbook utilizing input from Filipino culinary experts and a Registered Dietitian. The cookbook incorporates traditional Filipino recipes, excerpts from community members’ interviews, and nutrient analyses. Twenty Filipino-identifying individuals who self-reported physician-diagnosed hypertension were recruited from Filipino community-based organizations, enrolled into this study, provided with the cookbook, and asked to cook at least one recipe. Pre- and post-intervention surveys were conducted and centered around behavior change and features of the cookbook. This study provided evidence for the cookbook’s acceptability and feasibility, with participants’ open-ended responses revealing that the recipes, nutrition labels, illustrations, and cultural aspects of the cookbook increased motivation to achieve dietary change, including reducing sodium in their diet to improve their blood pressure. The results of this pilot study demonstrated acceptability of this cookbook and provided preliminary findings consistent with increased motivation in participants to make dietary changes and improve personal health, drawing attention to the importance of culturally-tailored health interventions. (250 words)
Keywords: Culturally tailored intervention, hypertension, cardiovascular disease
-
Kelsey Bernard (1), Jesus A. Mota (2), Paige Wene (3), Mandi J. Corenblum (3), Juben L. Saez (4), Mitchell J. Bartlett (3), M. Leandro Heien (5), Kristian P. Doyle (6), Robin Polt (5), Meredith Hay (4), Lalitha Madhavan (3,4,7), Torsten Falk (1,3,8)
(1)Physiological Sciences GIDP, The University of Arizona, Tucson, AZ
(2)Department of Biomedical Engineering, The University of Arizona, Tucson, AZ
(3)Department of Neurology, The University of Arizona, Tucson, AZ
(4)Department of Physiology, The University of Arizona, Tucson, AZ
(5)Department of Chemistry & Biochemistry, The University of Arizona, Tucson, AZ
(6)Department of Immunobiology, The University of Arizona, Tucson, AZ
(7)Evelyn F McKnight Brain Institute and BIO5 Institute, The University of Arizona, Tucson, AZ
(8)Department of Pharmacology, The University of Arizona, Tucson, AZ
Abstract: Parkinson’s Disease (PD) is a widespread disorder, however treatment focuses on resolution of motor symptoms with no therapeutics that accurately improve cognitive decline. Previous studies showed that MAS receptor agonism via the glycosylated angiotensin (1-7) peptide, PNA5, effectively reduces cognitive decline in models of vascular contributions to cognitive impairment and dementia. The goals of this study were to determine if administration of PNA5 decreased cognitive decline in a PD mouse model and to determine if improved cognitive status can be correlated to histopathological or blood-plasma changes. Mice over-expressing human, wild-type α-synuclein (αSyn) under the Thy1 promoter (Thy1-αSyn mice), served as a model of PD with cognitive decline compared with wild-type mice. At 4 months of age, Thy1-αSyn mice were treated with PNA5 or saline (1 mg/kg/day) and at 6 months, underwent various behavioral tests. Mouse brain tissue were analyzed for changes to brain pathology and blood plasma was examined with Multiplex Immunoassay for peripheral cytokine changes. PNA5 treatment reversed cognitive dysfunction measured by Novel Object Recognition and spontaneous alteration in a Y-maze in Thy1-αSyn mice. Fine-motor disturbances were unchanged indicating PNA5 treatment was specific to cognitive deficits. Decreases in hippocampal inflammation and reduction in levels of Macrophage Induced Protein (MIP-1β) was associated with enhanced cognition. Neuronal loss was also blunted within the CA3 hippocampal region of PNA5-treated αSyn mice. This data reveals that PNA5 treatment reduces cognitive dysfunction in a mouse model of PD and that MIP-1β can be used as a candidate biomarker for future target engagement.
Keywords: Parkinson’s Disease, Cognitive Decline, Hippocampus
Funding: Davies, Robert and Peyton, Parkinson’s Disease Research Fund to TF; Michael J Fox Foundation
grant 024922, NSF IOS-2207023, and UA Intramural funds to LM; and NIH pre-doctoral training grant
(T32 AG1081797) and Achievement Rewards for College Scientists (ARCS) support for KB.
University of Arizona FRONTERA and MARC program support to PW.
Conflict of Interest: Dr. Meredith Hay is the founder and CEO of ProNeurogen, Inc. a company that holds
exclusive rights to the clinical development of the Ang-(1-7)/MasR agonist described herein. This interest played no
role in the design of the studies; in the collection, analyses, or interpretation of data; in the writing of the Paper, or in the decision to present the results. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Poster Presentations
-
Daniel Hahn, OMS-III (1), Lauren Velasquez, OMS-III (1), Marc Mohammed, OMS-III (1), Dr. Albert Cooper, MD (2)
(1) Touro College of Osteopathic Medicine, New York, NY,
(2) Interfaith Medical Center, Brooklyn, NY
Introduction
Mesenteric hematomas are uncommon conditions usually linked to trauma, vascular diseases, or anticoagulation therapy. Spontaneous mesenteric hematomas are rarer and can result from vascular tension, such as hernias. This report presents a unique case of a mesenteric hematoma complicating a sigmoid colon hernia.
Case Presentation
An 89-year-old male with a reducible left inguinal hernia presented with abdominal pain and urinary symptoms. Imaging revealed a 14-cm mesenteric hematoma adjacent to the herniated sigmoid colon, which extended into the inguinal canal. Surgical exploration showed the hematoma obstructing hernia reduction, necessitating aspiration and decompression. Once reduced, the hernia was repaired with mesh placement.
Discussion
This case demonstrates a rare occurrence of a mesenteric hematoma caused by a vascular injury from herniated sigmoid colon traction. Unlike hematomas linked to trauma or anticoagulant therapy, this case involved mechanical vascular strain without anticoagulant use. Imaging confirmed the hematoma’s stable, clotted nature, consistent with venous origin. The hematoma’s size and position complicated surgical hernia reduction, highlighting the importance of individualized preoperative imaging and intraoperative flexibility. Decompression of the hematoma allowed safe hernia repair, emphasizing the significance of managing potential complications from both conditions. Additionally, this case underscores the bidirectional relationship between hernias and mesenteric hematomas: prior hernia-related vascular strain can predispose to hematoma formation, while hematomas can obstruct hernia repair.
Conclusion
This case highlights the importance of recognizing mesenteric hematomas as potential complications in long-standing hernias. Comprehensive imaging and adaptive surgical strategies are essential for successful outcomes in such complex cases.
Keywords: Mesenteric Hematoma, Inguinal Hernia, Vascular Injury
-
Gabriel P. Ordonez (1), Lauren F. Uchiyama, PhD (2), Khoi Pham (1), John P. Kennelly (2), Lany D. Tran (1), Peter Tontonoz, MD, PhD (2,3), Alexander H. Nguyen, MD, PhD (1)
(1)Vatche and Tamar Manoukian Division of Digestive Diseases, Department of Medicine, David Geffen School
Medicine, University of California, Los Angeles (UCLA) & UCLA Health;
(2)Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCL
(3)Department of Biological Chemistry, David Geffen School of Medicine at UC
Abstract: Peroxisome proliferator-activated receptor alpha (PPARa) is a nuclear hormone receptor that transcriptionally regulates lipid homeostasis and the liver fasting response through lipid uptake and catabolism. In humans, PPARa non-synonymous single nucleotide polymorphism (nsSNP) Val227Ala (V227A) occurs in East Asians with up to a 4% allele frequency. Clinical studies associate this variant with beneficial metabolic paramete including reduced plasma triacylglycerols (TG) and cholesterol, decreased metabolic dysfunction-associated steatotic liver disease (MASLD) incidence, and lowered body-mass index. Whether these correlations reflect causal relationship has not been physiologically modeled. To address this, we generated a V227A mouse model via CRISPR/Cas-mediated base editing of the endogenous Ppara gene locus. Base editing in mouse cell lines and pronuclei exhibits high editing efficiency. V227A mice display no difference in body or liver mass or hepatic accumulation. However, they exhibited decreased plasma TG, prominently under lipid-rich Western diet, aligning with clinical findings. Liver RNA sequencing confirmed upregulation of Ppara targets, including lipoprotein li (Lpl), the key enzyme in plasma TG hydrolysis. Gene expression analyses revealed increased liver and heart Lpl mRNA in fasted V227A mice. Notably, fasting and pharmacologic Ppara agonists induce Lpl mRNA, consistent with Lpl being a direct target. Functional TG assays showed increased TG uptake in the heart, and fluorometr assays confirmed elevated cardiac LPL activity. These findings suggest enhanced peripheral TG hydrolysis dr reduced plasma TG levels. Our study reveals a mechanistic link between PPARa-V227A and metabolic health, offering insights into human genetic variation and potential therapeutic targets in metabolic disease
Keywords: lipid metabolism, physiology, human genetic variation
-
Jasmine Santos (1,2), Gentian Lluri (1), Jamil Aboulhosn (1)
(1) Ahmanson/UCLA Adult Congenital Heart Disease Center
(2) University of the Philippines College of Medicine
Abstract (limit 250 words):
Patients with complex congenital heart disease require a palliative surgery called a Fontan procedure which creates a single-ventricle physiology. Virtually all Fontan patients develop Fontan Associated Liver Disease - a cause of major morbidity and mortality. But risk factors for disease progression are not fully understood. This study hypothesizes that Fontan patients with higher Fontan and/or Inferior Vena Cava (IVC) pressures will show liver fibrosis progression by serial liver biopsies. Fontan patients of the Ahmanson/UCLA Adult Congenital Heart Disease Center who had serial liver biopsies from 2009-2022 were identified. Fontan and IVC pressures measured during cardiac catheterization and liver biopsy results were extracted from medical records. METAVIR scoring for liver fibrosis was used. P-values were calculated using Chi-squared analysis. 21 patients had Fontan pressure measurements available, but only 17 had IVC pressure measurements. The threshold for “high” Fontan and IVC pressure was set at ≥ 15 mmHg. Among those with high Fontan pressures, 60% progressed versus 50% in low pressures (p = 0.67). Of those with high IVC pressures, 64% progressed, versus 50% in low pressures (p = 0.58). Upon lowering the threshold of IVC pressure to 14 mmHg, 66% vs 40% progressed in high vs low pressures respectively (p = 0.31). Lowering the threshold of Fontan pressure did not yield similar effects. This study was limited by small sample sizes from a single center. Although no statistical significance was found, it signals that IVC pressures might be a more sensitive predictor of liver fibrosis progression compared to Fontan pressures.
Keywords: Adults with Congenital Heart Disease, Fontan Circulation, Fontan Associated Liver Disease, Liver Disease Progression
-
NatalieDeana Badillo, BEng (1), Ana C. Krieger, MD, MPH (1,2)
(1) Weill Cornell Medicine, (2) Center for Sleep Medicine at Weill Cornell Medicine
Abstract: Idiopathic hypersomnia (IH) and narcolepsy are sleep disorders characterized by excessive daytime sleepiness and disrupted sleep patterns, often requiring complex diagnostic procedures. This project aims to develop a machine learning tool to improve the accuracy and speed of diagnosing these conditions by identifying key risk factors and enabling early detection. The goal is to create a more accessible and reliable diagnostic method validated against gold-standard sleep studies such as the Multiple Sleep Latency Test (MSLT) and polysomnography (PSG). The study analyzed 19,398 records from an academic sleep center, including clinical data, patient questionnaires, and polysomnography results collected over 10 years. Data preprocessing included normalization, handling missing values, and feature selection. Machine learning algorithms, including logistic regression and random forests, were used to develop predictive models trained on 80% of the dataset, with 20% reserved for validation and testing. Model performance was measured using accuracy, sensitivity, specificity, and AUC-ROC, with subgroup analyses ensuring generalizability across diverse populations. These models are expected to complement traditional diagnostic tools by identifying new clinical predictors, enhancing screening processes, and improving co-morbidity identification and management. With its uniquely large dataset, this project enables robust, data-driven predictions, reducing reliance on expensive diagnostic tests. The extensive data and curation enhance the predictive models’ reliability and open avenues for future research into links between sleep disorders and metabolic or neurological comorbidities. The impact of this work sets a precedent for applying machine learning to transform sleep medicine, enhance clinical screening for sleep disorders, and contribute to public health advancement.
Keywords: sleep medicine, machine learning, diagnostic accesibility, excessive daytime sleepiness
-
Ron Jako Domingo (1), Daniel Hahn (1) Vinay Tak, MD (2)
(1)Touro College of Osteopathic Medicine, New York, NY
(2)St. Mary’s General Hospital, Passaic, NJ
Spindle cell lipoma (SCL) is a rare, benign adipocytic tumor occurring in subcutaneous tissues, predominantly in older males and typically in the posterior neck, back, or shoulders. Histopathology, including CD34 and spindle cell morphology, distinguishes SCL from malignant neoplasms, such as liposarcomas.
Case Presentation
A 64-year-old female presented with a painless, left supraclavicular mass measuring 4.24 x 4.4 x 2.2 cm. Over nine months, the lesion grew to 7 x 6 x 5 cm. Imaging with a CT scan suggested a neoplastic process, raising concerns for malignancy. Fine needle biopsy confirmed a spindle cell lipoma with benign features, supported by CD34 positivity. Surgical excision revealed a well-circumscribed tumor without invasion into adjacent structures, consistent with SCL.
Discussion
This case illustrates the diagnostic complexity of SCL, particularly in atypical locations like the supraclavicular region or in female patients. Imaging, including MRI and CT, is crucial for evaluating tumor composition and margins, though low-fat variants can obscure visualization. Immunohistochemistry, specifically CD34 positivity and absence of markers such as SMA and Desmin, confirms the diagnosis. While SCL is slow-growing, atypical features such as rapid enlargement or unusual location may mimic malignancy, necessitating histopathological evaluation. Surgical excision remains the definitive treatment, with recurrence rates below 2% when complete resection is achieved. Early diagnosis and intervention prevent complications from mass effect or misdiagnosis.
Conclusion
A multidisciplinary approach involving imaging, biopsy, and surgical management ensures optimal outcomes for atypical SCL presentations. This case highlights the importance of early intervention to avoid diagnostic delays and unnecessary complications.
Keywords
Spindle Cell Lipoma, Benign Soft Tissue Tumors, Histopathology and Diagnosis
-
Mariel Aileen Buenavista Lansangan
Cedars Sinai Health Sciences University Graduate School of Biomedical Sciences
Coronary Artery Disease (CAD) is the third leading cause of death worldwide. Patients with a high BMI, diabetes, and severe hypertension face a subset of daily challenges, with many seeking surgical intervention to improve their quality of life. The expected surgical gold standard for treatment is conventional coronary artery bypass graft surgery (C-CABG). However, robotic-assisted technology in coronary artery bypass (RA-CAB) has been increasing in use as it provides a minimally invasive alternative to the C-CABG procedure, which utilizes a small anterior thoracotomy incision that eliminates the need for a cardiopulmonary machine. In this study, I hypothesize that using robot-assisted technology will lead to improved post-operative outcomes, including reduced levels of creatinine, ventilation hours, and surgical site bleeding, particularly in patients with high BMI, diabetes, and a diagnosis of CAD. Data on CABG and RA-CAB procedures was collected and analyzed from Cedars Sinai Medical Center between 2020 to 2024 (n=861) to compare procedure outcomes. Statistical tests in ANOVA will generate relationships between patient characteristics and outcomes by propensity score matching on covariates such as age, gender, weight, BMI, history of CAD, and diabetes. The research study will continue to review collected data until the end of 2024 to obtain an adequate sample size for comparison. Overall, the retrospective study aims to evaluate specific patient outcomes associated with each surgical procedure to support evidence-based practices so clinicians can provide higher standards of care through innovative technological advancements to reduce healthcare disparities across cultures.
Keywords: Robot-Assisted Cardiac Surgery
-
Angelina Jala (1), Bradley Johnson, MD-PhD (1), Qijun Chen, PhD (1)
(1) Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania,
Philadelphia, PA
Abstract: This study examines the role of telomeres in age-related causes of dementia, focusing on Alzheimer’s disease (AD) and primary age-related tauopathy (PART). Telomeres are protective structures at the ends of chromosomes that shorten with age and proteotoxic stress. This progressive shortening is hypothesized to drive neurodegenerative processes. Using telomere quantitative PCR (qPCR), we performed a blind associative study and produced T/S ratios (relative telomere length) in genomic DNA from peripheral blood samples. Samples from various disease groups were analyzed by T/S ratio and revealed consistent evidence of shorter telomeres in individuals with dementia compared to healthy controls (p = 0.0405). Nanopore sequencing, which has the potential to provide absolute telomere length measurements at single base resolution, was tested on PART samples, but did not yield conclusive results. Future research will expand the sample size and refine Nanopore techniques telomeres for more precise measurements of telomere length. This research contributes to a deeper understanding of the mechanisms causing age-related dementia and highlights the potential of telomere analysis as a biomarker for neurodegenerative diseases.
Keywords: telomeres, neurodegeneration, aging
-
Lauren Velasquez, OMS-III (1), Daniel Hahn, OMS-III (1), Dr. Bernard Pacella, MD (2)
(1) Touro College of Osteopathic Medicine, New York, NY,
(2) Wyckof Heights Medical Center, Brooklyn, NY
Papillary Thyroid Carcinoma (PTC) is the most common thyroid cancer, typically presenting as solid nodules. However, cystic variants (Cystic PTC) pose diagnostic challenges due to their atypical features and inconclusive fine-needle aspiration (FNA) results.
Case Presentation:
A 28-year-old female presented with a lateral neck mass initially classified as a benign cystic thyroid nodule (TI-RADS 4). Thyroid function tests were normal, and FNA cytology was Bethesda Category III (Atypia, Follicular Lesion of Undetermined Significance). Eight months later, the patient reported worsening hoarseness, dysphagia, and nodule growth (5.3 x 2.4 x 2.6 cm). Despite aspiration, the cyst recurred, prompting surgical excision. Pathology confirmed Cystic PTC with follicular nodular disease. The tumor was fully resected with clear margins and no vascular invasion.
Discussion:
Cystic thyroid nodules are typically benign, with malignancy risk around 6%. However, cystic variants of PTC present unique challenges: ultrasounds may underestimate malignancy, and FNA cytology is often inconclusive due to hypocellularity. For Bethesda III lesions, malignancy rates range from 6-48%, necessitating molecular testing or surgical intervention. Despite low suspicion on imaging, 80% of re-aspirated Bethesda III cystic PTC cases are malignant. Careful assessment of growth, clinical symptoms, and imaging findings, such as microcalcifications or irregular margins, is critical for timely diagnosis.
Conclusion:
In recent literature, an increasing number of Cystic PTC cases have been reported, potentially necessitating the subcategorization of Cystic PTC as its own subtype and clearer guidelines for management of cystic thyroid nodules with atypical features.
Keywords: Papillary Thyroid Carcinoma, Thyroid Cyst, Atypical Thyroid Features
-
Bradley Ventayen, B.S., Daniel Shoham, M.B.S, Tri Brian Nguyen, B.S., Jerome Torres, B.S., Ruth Sanchez, B.S., Breana Nguyen, B.S., Paul Medina, M.B.S, Clarisa Bloemhof, B.S., Ria Laxa, B.S., Christian Matabang, B.S., Ryan Lin, B.S., Kendrick Cruz, B.S., Celine Bojo, B.S., Haseeb Ahmad, B.S., Elvin Hernandez, DrPH, MPH, MCHES
California University of Science and Medicine - School of Medicine
Abstract
This cross-sectional cohort study explored the relationship between demographic factors and atherosclerotic cardiovascular disease (ASCVD) risk estimates among Filipino Americans aged 40-79 in Southern California's Inland Empire (IE). Data were collected at Bayanihan Project health fairs and included blood pressure, cholesterol levels, and survey responses addressing variables such as duration of U.S. residency, Filipino food consumption, education level, emotional support, income, smoking status, and sex. ASCVD risk was calculated using the American College of Cardiology’s Risk Estimate Tool.
Among 33 participants, no significant relationship was found between years spent in the U.S. and mean ASCVD risk (p=0.514). Similarly, no significance was observed between first- and second-generation Filipino Americans (p=0.514) or education level (p=0.428). However, daily consumption of Filipino food was significantly associated with higher ASCVD risk (13.40% vs. 5.50%, p=0.026). Emotional support also showed a significant impact, with participants lacking support having a mean ASCVD risk of 13.90% compared to 6.95% for those with support (p=0.006).
Income and ASCVD risk showed no statistical significance across all income brackets (p=0.426), nor did income levels below or above $50,000 annually (both p=0.06). However, sex was significantly associated with ASCVD risk, with males having a higher mean risk (14.61%) compared to females (7.77%, p=0.034).
These findings highlight the influence of dietary habits, emotional support, and sex on ASCVD risk in Filipino Americans. Further investigation on the dietary habits of Filipino Americans is warranted to understand the nutritional deficits of this community and tailor dietary interventions to the Filipino American community.
Keywords: Cardiovascular, Filipino Americans, Demographics
-
Bradley Ventayen, B.S., Daniel Shoham, M.B.S, Tri Brian Nguyen, B.S., Jerome Torres, B.S., Ruth Sanchez, B.S., Breana Nguyen, B.S., Paul Medina, M.B.S, Clarisa Bloemhof, B.S., Ria Laxa, B.S., Christian Matabang, B.S., Ryan Lin, B.S., Kendrick Cruz, B.S., Celine Bojo, B.S., Haseeb Ahmad, B.S., Elvin Hernandez, DrPH, MPH, MCHES
California University of Science and Medicine - School of Medicine
Abstract
Cardiovascular disease (CVD) is a leading cause of mortality worldwide, with disparities in risk across ethnic groups. Filipino Americans, identified as a high-risk population by the American Heart Association, experien elevated risks for atherosclerotic cardiovascular disease (ASCVD). Despite this, research on their specific ri factors remains limited. This study compares ASCVD risk estimates between Filipino Americans in Southern California's Inland Empire (IE) and ethnically diverse populations from the National Health and Nutrition Examination Survey (NHANES).
Using the American College of Cardiology’s ASCVD Risk Estimate tool, data were collected from 36 Filipino Americans (ages 40-79) at community health fairs. Results were compared to 2,497 participants from NHANES (2017-2020), representing various ethnicities. Analysis using a non-parametric One-Way ANOVA on Ranks revealed significantly higher 10-year ASCVD risk estimates for Inland Empire Filipinos (mean 9.10%) compared “Mexican-Americans” (5.65%), “Other Hispanics” (6.20%), and “Other Races” (5.71%) (p<0.05). No significa differences were found when compared to “Non-Hispanic White” (7.51%) and “Non-Hispanic Black” (8.18 groups.
These findings underscore the elevated ASCVD risk among Filipino Americans, attributed to dietary habits, physic inactivity, and cultural influences. The study highlights the urgent need for culturally tailored interventions address this health disparity. Public health strategies should focus on promoting heart-healthy diets, increasing physical activity, and reducing smoking and alcohol consumption. Such efforts could improve cardiovascul outcomes for Filipino Americans and advance equity in cardiovascular health.
Keywords: Cardiovascular, Filipino Americans, NHANES
Meet the Presenters
-
Sheena Garcia
Oral & Poster Presentation
-
Gabriel Ordonez
Oral & Poster Presentation
-
David Pack
Oral & Poster Presentation
-
Juben Saez
Oral & Poster Presentation
-
Natalie Badillo
Poster Presentation
-
Angeline Blancia
Poster Presentation
-
Angela Rose David
Poster Presentation
-
Ron Jako Domingo
Poster Presentation
-
Daniel Hahn
Poster Presentation
-
Angelina Jala
Poster Presentation
-
Mariel Lansangan
Poster Presentation
-
Jasmine Santos
Poster Presentation
-
Lauren Velasquez
Poster Presentation
Meet the Judges
-
Gene Ables, PhD
Associate Science Director
Orentreich Foundation for the Advancement of Science, Inc. (OFAS)
Cold Spring, New York, USADr. Ables received his degree of Doctor of Veterinary Medicine from the University of the Philippines Los Banos. He then obtained his PhD from Hokkaido University (Japan). His post-doctoral research in Preventive Medicine and Nutrition at Columbia University focused on liver lipid metabolism. In 2006, he was appointed Associate Research Scientist at the Columbia University Medical Center. Dr. Ables joined OFAS in April 2011. His research focuses on the effects of SAAR in different tissues using animal models of disease.
-
Benedicto Borja, MD
Program Director, Psychiatry Residency Training Program
George Washington University School of Medicine
Washington D.C., USADr. Benedicto Borja is currently the Program Director for the George Washington University Department of Psychiatry Residency Training Program. Prior to coming to GW, he served as Director of Education at the Sheppard Pratt Health System and the Associate Program Director at the University of Maryland/Sheppard Pratt Psychiatry Residency Training Program where he completed his residency as chief resident. His major areas of clinical expertise include emergency psychiatry and telepsychiatry and EMDR. He was instrumental in creating the first Psychiatric Emergency Services in Baltimore at the University of Maryland and was also instrumental in the development of the Crisis Walk In Clinic at Sheppard Pratt. He served as the founding Medical Director for both. Dr. Borja had served as a Senior Oral Board Examiner for the American Board of Psychiatry & Neurology (ABPN) from 2002 to 2015.
-
Kassandra Coronel, MD, PgCert
CYFAM Secretary Chair, MGB Resident Community Rotation Supervisor
Harvard Medical School
Boston, Massachusetts, USA -
Franco Felizarta, MD, FACP, FAPCR, CPI, AAHIVS
Director of the Antibiotic Stewardship Program (HIV & ID Specialist)
Bakersfield Memorial Hospital (Dignity Health)
Bakersfield, California, USA -
Lilia Fernando, PhD
Associate Professor
University of the Philippines, Los Baños
Los Baños, PhilippinesDr. Lilia M. Fernando-Corpuz is a biochemist specializing in plant growth-promoting bacteria and nanomaterials for crop productivity and safety. Her research includes nanobiosensors for agricultural, environmental, and medical applications, leading to patents and publications. She is an Associate Professor and UP Scientist at the Institute of Crop Science, University of the Philippines Los Baños (UPLB), where she teaches agricultural biotechnology and biochemistry. She co-founded MakilingTek Inc., a university spin-off commercializing microbial inoculants and nanobiotechnologies. Dr. Fernando-Corpuz earned her Ph.D., M.S., and B.S. in Biochemistry and Chemistry from UPLB. A former DOST Scholar, she conducted Ph.D. research at Michigan State University and postdoctoral studies at MIT on phage- and yeast-display techniques for agriculture.
-
Antonio Moya, MD, MPH
CYFAM Founder & Trustee, Professor Neurology
Keck School of Medicine of USC
Los Angeles, California, USA -
Vachel Paller, PhD
Professor
University of the Philippines, Los Baños
Los Baños, PhilippinesDr. Vachel Gay V. Paller is a Professor and UP Scientist 3 at the Institute of Biological Sciences, College of Arts and Sciences in UP Los Banos. Upon obtaining her doctorate degree in Kobe University, Japan in 2008, Dr. Paller continued her passion for teaching and research. Her selfless dedication has earned her prestigious awards such as the 2021 Department of Science and Technology- National Research Council of the Philippines Outstanding Achievement Award, 2021 University of the Philippines Los Banos (UPLB) Outstanding Researcher Award (Senior Category for Biological Sciences), 2016 UPLB Outstanding Teacher Award (OTA), and 2014 UPLB Ten Outstanding Alumni Award (TOUAA).
-
Melissa Palma, MD, MPH
Clinical Assistant Professor of Family Medicine
Brown University
Providence, Rhode Island, USA -
Joseph Puyat, MSc, MA, PhD
Assistant Professor
University of British Columbia
Kelowna, British Columbia, Canada -
Mericien Venzon, MD, PhD
Pediatrics Resident, Physician-Scientist Program
University of California, Los Angeles
Los Angeles, California, USAMericien Venzon or Cien is a California, Bay Area native who is currently a pediatric resident at UCLA whose research focuses on the role of the gut microbiome in pediatric allergy as part of the Physician Scientist Training Program. She earned her MD-PhD from NYU School of Medicine in 2024. She served as co-chair of the CYFAM Research Committee from 2020-2022, was a featured panelist for the Filipino-American Health Forum on COVID-19, and conducted research on Filipinx health disparities as a fellow of the Tayo division of the Filipino Young Leaders program. Currently she serves as co-manxng for the CYFAM Research Committee. Her favorite Filipino dish is her Lola's miswa soup with patola and she has visited her family in Manila/Pampanga many times as the previous Philippine Figure Skating Champion and member of the Asian Olympic Team.
-
Neil Wingkun, MD, MPH
Emergency Physician
Houston Methodist
Houston, Texas, USA